January 16, 2019
1 min read
Save

Telehealth identifies liver transplantation noncandidates

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Telehealth-based evaluations identified patients with chronic liver disease who were not candidates for liver transplantation without the need for additional testing, according to a study published in Clinical Gastroenterology and Hepatology.

“Because of limited access to transplant centers, patients often travel long distances to be evaluated for [orthotopic liver transplant],” Venkata Rajesh Konjeti, MD, from the Virginia Commonwealth University, and colleagues wrote. “Our data indicate that a telehealth-based triage reduces futile transplant evaluations by approximately 60%.”

To increase access to specialty care, the Department of Veterans Affairs introduced the Specialty Care Access Network–Extension of Community Healthcare Outcomes (SCAN-ECHO) program, designed to offer gastroenterology and hepatology subspecialty telehealth evaluations.

“SCAN-ECHO offers an option for the referring provider to obtain a preliminary analysis of candidacy before completing a full work-up,” the researchers wrote.

The study comprised 190 patients who were referred for transplantation between August 2012 and September 2016, 91 of whom presented through the SCAN-ECHO program and the rest referred directly.

Patients evaluated through SCAN-ECHO were less likely to be deemed noncandidates for transplantation at the time of initial referral (0% vs. 41%; P < .001) and after a complete liver transplantation work-up (23.1% vs. 55.6%; P < .001).

Fewer patients in the SCAN-ECHO group were turned down for transplantation because of psychosocial issues (4.4% vs. 14.1%; P = .02), comorbidities (7.7% vs. 11.1%), or progression of HCC beyond Milan (6.6% vs. 13.1%).

“We believe that expanding SCAN-ECHO to other solid-organ transplant centers within the VA and elsewhere has the potential to improve access, reduce costs, and minimize futile testing of patients,” Konjeti and colleagues wrote. – by Talitha Bennett

Disclosure: The authors report no relevant financial disclosures.